This December, Keyline is encouraging each of its branches to raise at least £150 for the charity to help ensure Prostate Cancer UK can maintain their vital research work during these challenging times. £5,000 could help pay for essential research equipment, such as an incubator that could help researchers grow cells to test in the lab, a hugely beneficial way of testing new treatments for prostate cancer.
Tracey Pritchard, Director of Fundraising and Supporter Engagement at Prostate Cancer UK said: “Keyline have been amazing partners over the last decade, and it’s fantastic to know they’re pledging to continue that support this December.
"Prostate cancer is now the most commonly diagnosed cancer in the UK and due to the impact of the Covid-19 pandemic, our life-saving research is at risk. However, the wonderful support of our partners like Keyline has allowed us to protect research into better tests and treatments, to stop prostate cancer being a killer.
"We are so grateful to Keyline and thank them for their continued support.”